September 24th 2024
During a Case-Based Roundtable® event, Michael R. Bishop, MD, moderated a discussion on monitoring and treatment of chronic graft-vs-host disease.
September 24th 2024
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
KRd-ASCT Improves Long-Term PFS in Multiple Myeloma
October 3rd 2021Promising survival results were shown in the FORTE trial of carfilzomib plus lenalidomide, and dexamethasone induction/consolidation with autologous stem cell transplant and maintenance with carfilzomib-lenalidomide in patients with multiple myeloma.
Read More
Prolonged Reponses Following ASCT and Standard Consolidation/Induction With Daratumumab Maintenance
June 20th 2021Benefit was seen with daratumumab maintenance therapy for patients with newly diagnosed multiple myeloma who received autologous stem cell transplant plus induction and consolidation therapy with bortezomib, thalidomide, and dexamethasone.
Read More